Vanguard Group Inc. Has $173.70 Million Stock Holdings in Sotera Health Company $SHC

Key Points

• Vanguard Group Inc. reduced its stake in Sotera Health Company by 0.2%, now holding 14,897,175 shares worth approximately $173.7 million.
• Sotera Health reported a quarterly EPS of $0.20, exceeding expectations, with revenue of $294.34 million, which is up 6.4% year-over-year.
• While some analysts downgraded their ratings, others upgraded Sotera Health, with a consensus target price of $16.00 and a rating of "Moderate Buy."

Vanguard Group Inc. lowered its holdings in Sotera Health Company (NASDAQ:SHC - Free Report) by 0.2% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,897,175 shares of the company's stock after selling 26,371 shares during the period. Vanguard Group Inc. owned about 5.25% of Sotera Health worth $173,701,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC lifted its stake in Sotera Health by 4,881.9% in the first quarter. Farther Finance Advisors LLC now owns 6,327 shares of the company's stock valued at $70,000 after acquiring an additional 6,200 shares during the last quarter. Teacher Retirement System of Texas acquired a new stake in Sotera Health in the first quarter valued at $266,000. BNP Paribas Financial Markets acquired a new stake in Sotera Health in the fourth quarter valued at $208,000. Principal Financial Group Inc. lifted its stake in Sotera Health by 0.3% in the first quarter. Principal Financial Group Inc. now owns 352,388 shares of the company's stock valued at $4,109,000 after acquiring an additional 1,037 shares during the last quarter. Finally, Ananym Capital Management LP acquired a new stake in Sotera Health in the fourth quarter valued at $13,680,000. Institutional investors and hedge funds own 91.03% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Wall Street Zen upgraded shares of Sotera Health from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 16th. The Goldman Sachs Group upgraded shares of Sotera Health from a "neutral" rating to a "buy" rating and increased their price target for the company from $14.00 to $17.00 in a research note on Monday, May 5th. Finally, Barclays reiterated an "overweight" rating on shares of Sotera Health in a research note on Friday, August 8th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $16.00.

Sotera Health Stock Performance

Sotera Health stock traded up $0.01 during midday trading on Tuesday, hitting $16.40. The company's stock had a trading volume of 1,513,353 shares, compared to its average volume of 1,651,989. Sotera Health Company has a 1-year low of $9.53 and a 1-year high of $17.08. The company has a debt-to-equity ratio of 4.49, a current ratio of 2.47 and a quick ratio of 2.23. The company has a 50-day moving average price of $12.56 and a two-hundred day moving average price of $12.20. The company has a market cap of $4.66 billion, a price-to-earnings ratio of 205.03 and a beta of 1.81.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings data on Friday, August 8th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.03. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The business had revenue of $294.34 million during the quarter, compared to analysts' expectations of $275.81 million. During the same quarter in the previous year, the company earned $0.19 EPS. The business's revenue was up 6.4% on a year-over-year basis. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. As a group, sell-side analysts predict that Sotera Health Company will post 0.61 earnings per share for the current year.

Insiders Place Their Bets

In other Sotera Health news, insider Michael P. Rutz sold 126,611 shares of Sotera Health stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $16.38, for a total value of $2,073,888.18. Following the completion of the sale, the insider owned 450,204 shares in the company, valued at $7,374,341.52. The trade was a 21.95% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 55.12% of the stock is owned by company insiders.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.